In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 126456-43-7, name is (1S,2R)-1-Amino-2,3-dihydro-1H-inden-2-ol, introducing its new discovery. Safety of (1S,2R)-1-Amino-2,3-dihydro-1H-inden-2-ol
A discovery tool at work: The unexpected properties of a two-carbon residue
We report the very easy preparation of novel peptides 6a-n as represented by CF3CH2(L)Phe(L)IleOtBu (6a), a prospective antitumor compound. Peptides such as 6a are directly obtained via standard chemistry from a novel class of amino acids, Nalpha-trifluoroethyl amino acids 4. In fact, unexpectedly, the Nalpha-1,1,1-trifluoroethyl substitution completely deactivates the alpha-nitrogen. That is, compounds 4 behave exactly like Nalpha-protected amino acids, and take part in standard peptide synthesis accordingly. Representative compounds 4a-c are prepared by reaction of commercial amino acid t-butyl esters 2a-c with 1 eq iodonium salt 1 in dichloromethane/water at 22C in 1 h or less. The reaction is promoted by NaHCO3 (1.5 eq). The intermediate Nalpha-1,1,1-trifluoroethyl t-butyl esters 3a-c are hydrolyzed and separated from coproducts at the same time by treatment with aqueous HCl at 22C. Evaporation of the acid extracts provides analytically pure 4a-c in 78-98% yields.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 126456-43-7, and how the biochemistry of the body works.Safety of (1S,2R)-1-Amino-2,3-dihydro-1H-inden-2-ol
Reference£º
Chiral nitrogen ligands in late transition metal-catalysed asymmetric synthesis¡ªI. Addressing the problem of ligand lability in rhodium-catalysed hydrosilations,
Nitrogen-Containing Ligands for Asymmetric Homogeneous and Heterogeneous Catalysis